It is a synthetic analogue of the human incretin hormone GLP-1, designed to have increased resistance to degradation by the dipeptidyl peptidase-4 (DPP-4) enzyme, resulting in a significantly extended half-life
However, individual responses vary, and semaglutide may be more accessible or affordable depending budget
Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial
Consultations with Medical Practitioners Before you can even think about getting a prescription for weight loss injections, you'll need to consult with a medical practitioner
Here, Regeneron could chart a course for a better tolerated, but less efficacious, lean mass sparing weight loss combination with their anti-myostatin Route of Administration - Here, oral options might win if companies like Structure Therapeutics can solve the tolerability issues